A convenient synthesis of an original, bifunctional chelator based on an ON2S ligand and its coordination chemistry with the oxorhenium(v) core

European Journal of Organic Chemistry

Volumn , Issue 6, 2006, Pages 1483-1488

  Le Gal, Julien ^a   Benoist, Eric ^a  

^a Laboratoire de Chimie Inorganique   (France)

Author keywords

Chelates; Conjugation; N,O ligands; Rhenium

Indexed keywords

EID: 33645086350     PISSN: 1434193X     EISSN: 10990690     Source Type: Journal    
DOI: 10.1002/ejoc.200500810     Document Type: Article

References (39)

1. The Chemistry of Contrast Agents in Medicinal Magnetic Resonance Imaging (Eds.: A. E. Merbach, E. Tohl), Wiley, Chichester, 2001.
2. a) D. Parker, Chem. Soc. Rev. 1990, 19, 271-291;
3. b) S. Liu, Chem. Soc. Rev. 2004, 33, 445-461.
4. a) R. D. Hancock, A. E. Martell, Chem. Rev. 1989, 89, 1875-1914;
5. b) A. S. De Sousa, G. J. B. Croft, C. A. Wagner, J. P. Mickael, R. D. Hancock, Inorg. Chem. 1991, 30, 3525-3529;
6. c) A. S. De Sousa, R. D. Hancock, J. Chem. Soc., Chem. Commun. 1995, 415-416.
7. a) A. Loussouarn, M. Duflos, E. Benoist, J.-F. Chatal, G. Le Baut, J.-F. Gestin, J. Chem. Soc., Perkin Trans. 1 1998, 237-241;
8. b) A. Loussouarn, A. Ouadi, L. Morandeau, P. Remaud, R. Giles, J. F. Gestin, J. Webb. Tetrahedron Lett. 2003, 44, 3539-3541.
9. S. G. Gouin, J.-F. Gestin, A. Reliquet, J. C. Meslin, D. Deniaud, Tetrahedron Lett. 2002, 43, 3003-3005.
10. L. J. Charbonnière, N. Weibel, R. F. Ziessel, J. Org. Chem. 2002, 67, 3933-3936.
11. A. K. Mishra, J.-F. Chatal, New J. Chem. 2001, 25, 336-339.
12. C. Wu, H. Kobayashi, B. Sun, M. Yoo, C. H. Paik, O. A. Gansow, J. A. Carrasquillo, I. Pastan, M. W. Brechbiel, Bioorg. Med. Chem. 1997, 5, 1925-1934.
13. a) M. W. Brechbiel, O. A. Gansow, J. Chem. Soc., Perkin Trans. 1 1992, 1173-1178;
14. b) M. W. Brechbiel, O. A. Gansow, C. G. Pippin, R. D. Rogers, R. P. Planalp, Inorg. Chem. 1996, 35, 6343-6348.
15. E. A. Lewis, C. C. Allan, R. W. Boyle, S. J. Archibald, Tetrahedron Lett. 2004, 45, 3059-3062.
16. a) S. G. Gouin, E. Benoist, J.-F. Gestin, J.-C. Meslin, D. Deniaud, Eur. J. Org. Chem. 2004, 878-885;
17. b) S. G. Gouin, J.-F. Gestin, L. Morandeau, F. Segat-Dioury, J.-C. Meslin, D. Deniaud, Org. Biomol. Chem. 2005, 3, 454-461.
18. B. S. Chhikara, N. Kumar, V. Tandon, A. K. Mishra, Bioorg. Med. Chem. 2005, 13, 4713-4720.
19. M. Papachristou, I. Permettis, T. Siatra-Papastaikoudi, M. Pelecanou, C. Tsoukalas, C. P. Raptopoulou, A. Terzis, E. Chiotellis, M. Papadopoulos, Eur. J. Inorg. Chem. 2003, 3826-3830.
20. a) L. Fourteau, E. Benoist, M. Dartiguenave, Synlett 2001, 1, 126-128;
21. b) J. Le Gal, E. Benoist, M. Gressier, Y. Coulais, M. Dartiguenave, Tetrahedron Lett. 2002, 43, 9295-9297;
22. c) J. Le Gal, PhD thesis, University of Toulouse, 2004;
23. d) J. Le Gal, L. Latapie, M. Gressier, Y. Coulais, M. Dartiguenave, E. Benoist, Org. Biomol. Chem. 2004, 2, 876-883.
24. J. Le Gal, F. Tisato, G. Bandoli, M. Gressier, J. Jaud, S. Michaud, E. Benoist, Dalton Trans. 2005, 3800-3807.
25. S. Liu, D. S. Edwards, in Technetium and Rhenium in Chemistry and Nuclear Medicine 4 (Eds.: M. Nicolini, U. Mazzi), SGEditoriali, Padova, Italy, 1994, pp. 383-386.
26. M. R. Bermejo, A. M. Gonzalez, M. Fondo, A. Garcia-Deibe, M. Maneiro, J. Sanmartin, O. L. Hoyos, M. Watkinson, New J. Chem. 2000, 24, 235-241.
27. a) R. C. Larock, Comprehensive Organic Transformations, VCH Publishers, New York, 1989, pp 411;
28. b) J. P. Adams, J. Chem. Soc., Perkin Trans. 1 2002, 2586-2597.
29. a) A. R. Boothroyd, M. A. Kerr, Tetrahedron Lett. 1995, 36, 2411-2414;
30. b) P. Haquette, S. Dagorne, R. Welter, G. Jaouen, J. Organomet. Chem. 2003, 682, 240-247;
31. c) P. Selvam, S. K. Mojapatra, S. U. Sonavane, R. V. Jayaram, Tetrahedron Lett. 2004, 45, 2003-2007.
32. L. G. Luyt, J. A. Katzenellenbogen, J. Labelled Compd. Radiopharm. 2001, 44, S773-S774.
33. J. Chatt, G. A. Rowe, J. Chem. Soc. 1962, 4019-4033.
34. R. Visentin, R. Rossin, M. C. Giron, A. Dolmella, G. Bandoli, U. Mazzi, Inorg. Chem. 2003, 42, 950-959.
35. C. J. Smith, T. J. Hoffman, C. Higginbotham, E. Wong, D. Esihmia, J. R. Thornback, W. A. Volkert, J. Nucl. Med. 1998, 39, 215P.
36. P. A. Schubiger, R. Alberto, A. Smith, Bioconjugate Chem. 1996, 7, 165-179.
37. Unpublished work realized on two batches of three male rats. %(Injected Dose)/organ (5 min p.i./30 min p.i.): liver: 22.36/ 9.17%; blood: 31.79/11.23%; kidneys: 10.50/6.55%; urine: 1.08/10.50%.
38. The ethyl β-alanine ester was used to model peptide conjugation because this compound has been introduced generally as a spacer between the biomolecule and the bifunctional chelator to minimize interference from the chelator upon binding to the peptide/receptor.
39. R. A. Bell, D. W. Hughes, C. J. L. Lock, J. F. Valliant, Can. J. Chem. 1996, 74, 1503-1511.